文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Nanoscale CaO materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model.

作者信息

Wang Yingliang, He Xuelian, Zhou Chen, Bai Yaowei, Li Tongqiang, Liu Jiacheng, Ju Shuguang, Wang Chaoyang, Xiang Guangya, Xiong Bin

机构信息

Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Key Laboratory of Molecular Imaging, Wuhan 430022, China.

School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

出版信息

Acta Biomater. 2022 Dec;154:536-548. doi: 10.1016/j.actbio.2022.09.074. Epub 2022 Oct 12.


DOI:10.1016/j.actbio.2022.09.074
PMID:36241014
Abstract

Transcatheter arterial chemoembolization (TACE) is extensively used in the treatment of hepatocellular carcinoma (HCC), but its efficacy is usually limited to secondary tumor hypoxia and other progressive exacerbation of the abnormal tumor microenvironment (TME). Herein, we synthesized polyvinyl pyrrolidone (PVP)-coated CaO nanoparticles (CaO NPs) and applied them as a synergistic agent to improve the antitumor efficacy of TACE. After injection into the tumor, CaO NPs reacted with water to generate abundant oxygen, hydroxyl ions (OH), and calcium ions (Ca), thereby relieving tumor hypoxia, neutralizing acid, and overloading Ca to mediate antitumor effects. Moreover, the effect of chemotherapeutic drugs within the TACE was improved due to the modulated TME. CaO NPs efficiently regulated the TME and improved the antitumor effect of doxorubicin under hypoxia conditions in vitro. Compared to other groups, the TACE+CaO NPs group achieved the lowest tumor growth rate, highest tumor necrosis rate, lowest expression of histological markers associated with hypoxia and angiogenesis (HIF-α, VEGF, and CD31), and highest CD8 T cell recruitment in vivo. Thus, these findings demonstrated that CaO NPs provide synergy for TACE therapy in the VX2 orthotopic rabbit liver cancer model, suggesting that they have a potential broad clinical application. STATEMENT OF SIGNIFICANCE: The efficacy of transcatheter arterial chemoembolization (TACE) for treatment of hepatocellular carcinoma is usually limited to secondary tumor hypoxia and other progressive exacerbation of the abnormal tumor microenvironment (TME). To address this issue, we synthesized CaO nanoparticles (CaO NP) which would react with water to generate abundant oxygen, hydroxyl ions (OH), and calcium ions (Ca), thereby relieving tumor hypoxia, neutralizing the acidic TME, and inducing Ca overloading. The efficacy of CaO NPs in combination with TACE was investigated in an orthotopic rabbit liver cancer model, and the results showed the great synergetic antitumor effect of TACE and CaO NPs.

摘要

相似文献

[1]
Nanoscale CaO materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model.

Acta Biomater. 2022-12

[2]
Autophagy-Targeted Calcium Phosphate Nanoparticles Enable Transarterial Chemoembolization for Enhanced Cancer Therapy.

ACS Appl Mater Interfaces. 2023-3-8

[3]
Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.

Acta Biomater. 2023-2

[4]
Synergistic Effects of Nanoscale CaO Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination.

Int J Nanomedicine. 2024

[5]
Relaxin combined with transarterial chemoembolization achieved synergistic effects and inhibited liver cancer metastasis in a rabbit VX2 model.

J Cancer Res Clin Oncol. 2024-7-2

[6]
Sustained release hypoxia-activated prodrug-loaded BSA nanoparticles enhance transarterial chemoembolization against hepatocellular carcinoma.

J Control Release. 2024-8

[7]
Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.

Theranostics. 2021

[8]
Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.

J Vasc Interv Radiol. 2022-10

[9]
Transcatheter arterial chemoembolization (TACE) with iRGD peptide in rabbit VX2 liver tumor.

J Cancer Res Ther. 2020

[10]
Radioiodine-131-Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor.

Adv Healthc Mater. 2023-12

引用本文的文献

[1]
Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study.

Sci Adv. 2025-7-4

[2]
Real-world status, efficacy and prognosis analysis of first-line treatment for unresectable hepatocellular carcinoma in patients treated at multiple centres.

Ann Med. 2024-12

[3]
Synergistic Effects of Nanoscale CaO Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination.

Int J Nanomedicine. 2024

[4]
Temperature sensitive nanogel-stabilized pickering emulsion of fluoroalkane for ultrasound guiding vascular embolization therapy.

J Nanobiotechnology. 2023-11-9

[5]
Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma.

Mater Today Bio. 2023-8-14

[6]
Microfluidic fabrication of X-ray-visible sodium hyaluronate microspheres for embolization.

RSC Adv. 2023-7-10

[7]
Advances in experimental animal models of hepatocellular carcinoma.

Cancer Med. 2023-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索